New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BBY;ADBE;ALXA;BV;ZQK;CYTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2015
10:48 EDTBBYGoPro soars after Citi ups target to $90 on drone, VR potential
Subscribe for More Information
July 30, 2015
10:13 EDTBBYOptions with increasing implied volatility
Options with increasing implied volatility: ESPR SRPT CX RAX YY SPLK QIHU HFC OWW BBY
09:01 EDTBBYAmerican Express, Best Buy announce e-commerce technology integration
Subscribe for More Information
08:14 EDTCYTXCytori Therapeutics says company-supported trial in Japan to begin enrollment
Subscribe for More Information
July 29, 2015
10:41 EDTBBYOptions with increasing implied volatility
Subscribe for More Information
10:27 EDTBBYOptions with decreasing implied volatility
Subscribe for More Information
July 28, 2015
09:18 EDTCYTXOn The Fly: Pre-market Movers
Subscribe for More Information
08:10 EDTCYTXCytori licensee Kerastem receives conditional FDA approval for alopecia trial
Cytori Therapeutics announced that Kerastem Technologies, a wholly owned subsidiary of Bimini Technologies, received U.S. FDA conditional Investigational Device Exemption approval to conduct a clinical trial studying the safety and feasibility of its technology for the treatment of female and early male pattern baldness.The phase II study, known as the STYLE trial, follows initial clinical work in Europe and Japan. This clinical experience served as a basis for the FDA IDE submission. The data will be presented in September at the 2015 International Society of Hair Restoration Surgery meeting in Chicago. STYLE is a 70 patient controlled trial that is expected to begin enrollment in late 2015 at up to eight centers within the United States. The primary endpoint is safety and tolerability of the treatment and secondary endpoints include change in hair growth and density. In 2013, Bimini, a private medical technology company, acquired global and exclusive rights to commercialize Cytori Celution Technology for alopecia and hair related indications. Under the commercial agreement, Bimini will be responsible for all key activities including clinical studies, regulatory approvals, and market development. Bimini will acquire Cytori products at agreed upon transfer pricing and pay Cytori a perpetual royalty on sales.
July 27, 2015
06:05 EDTBBYBest Buy to begin selling Apple Watch in August, WSJ reports
Subscribe for More Information
July 23, 2015
19:24 EDTBBYWal-Mart's Apple Pay competitor launching soon, Bloomberg says
CurrentC, the mobile payment application funded by Wal-Mart (WMT), Target (TGT), Best Buy (BBY) and others, will see an early trial run next month, Bloomberg reported earlier, citing three people familiar with the situation. A spokesperson for Lowe's (LOW) said the consortium behind the app expects an official launch in Q3, and Bloomberg noted that CurrentC will compete with more "established" offerings such as Apple's (AAPL) Apple Pay and Google's (GOOG) Android Pay. Reference Link
July 20, 2015
09:31 EDTBBYBest Buy store rationalization to be catalyst, says BB&T
Subscribe for More Information
09:02 EDTADBEAdobe names Abhay Parasnis as CTO, senior VP of Platform Technology & Services
Adobe named Abhay Parasnis as chief technology officer and senior vice president of platform technology and services. Parasnis will drive Adobe’s technology strategy, architecture and innovation roadmap for its cloud services, focusing on integration of its three cloud services; providing a consistent customer experience via the cloud; and enabling the company’s cloud-based go-to-market strategies. Parasnis brings nearly 20 years of experience in the software industry. Most recently, he was president and chief operating officer of venture-funded enterprise mobility leader Kony.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use